Case Report: Fatal myocarditis after combination of immune checkpoint inhibitor and platinum doublet chemotherapy [version 1; peer review: 1 not approved]
Myocarditis is a rare but feared adverse event of treatment with immune checkpoint inhibitors. The incidence is about 1%, while the mortality rate is up to 50%. Many physicians treating lung cancer do not have experience with this serious adverse event, and few hospitals in Scandinavia have routines...
Gespeichert in:
| Veröffentlicht in: | F1000 research 2021, Vol.10, p.30 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!